Accelerate licensing & partnership decisions

De-risk in-licensing decisions and move faster on the right programs

Identify, track, and triage the best drug programs

95% of deals do not pass due diligence processes and simply waste time, effort, and resources. Efficiently sift through hundreds of opportunities with VibeOne and focus on only those that truly align with your strategy.

Speed

Build focused opportunity lists in days vs. months

Scale

Evaluate hundreds of assets with fewer resources

Trust

Transparent, traceable scoring ensures defensive, data-backed decisions

Global

Seamlessly integrate non-English data, uncovering overlooked assets

PTRS Analysis Product screenshot.

Comprehensive top-to-bottom diligence

  • Scan landscapes and your funnel for high potential programs
  • Identify strategic fits aligned with your scientific, financial, and commercial goals
  • Track competitive markets, assets, and your opportunity in real-time
  • Create custom evaluations against your internal profile
  • Quickly perform deep diligence and risk scoring against biology, CMC, clinical, and regulatory criteria

Accelerate search & evaluation

Save time and money while streamlining due diligence with VibeOne.

Challenges vs. advantages: How VibeOne delivers

Challenge

  • Volume overload: Hundreds of early-stage opportunities
  • Resource bottlenecks: Low-value assets waste time and energy
  • Biased decision-making: Familiarity and recency biases result in poor decisions
  • Language & regional barriers: Lack of in-house foreign language skills results in missed opportunities
  • Scale intelligently: Narrow focus with data-powered research instead of brute-force screening
  • Efficiency boost: Eliminate poor fits early and assign internal experts only to high-probability assets
  • Objective rigor: Apply consistent, transparent evaluation frameworks across programs and indications
  • Global intelligence: Automatically translate and contextualize data from foreign biopharmas (e.g. Chinese drug programs)

Learn how VibeOne evaluates and compares drug assets, helping you identify high potential development opportunities more quickly.